All News MedMira Inc.

Equities

MIR

CA58501R1029

Market Closed - Toronto S.E. Other stock markets 03:30:29 2024-05-17 pm EDT			5-day change	1st Jan Change
0.095 ^CAD	+5.56%		+5.56%	-13.64%

Apr. 02	MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
Mar. 27	Samsung Pay to stop working with Russia's Mir payment system from April 3	RE

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	Apr. 01	CI
Samsung Pay to stop working with Russia's Mir payment system from April 3	Mar. 27	RE
MedMira Says Received Canadian Patent for its Quantitative Diagnostic System	Mar. 13	MT
MedMira Brief: Says Received Canadian Patent for its Quantitative Diagnostic System	Mar. 13	MT
MedMira's Fiscal Q1 Loss Widens, Revenue Drops	Jan. 02	MT
MedMira Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	Dec. 28	CI
U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test	Dec. 13	CI
MedMira Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	Nov. 27	CI
Medmira Inc. Provides Update on Its Progress to Achieve Regulatory Approval in Canada and the USA for Its Infectious Disease Rapid Tests	23-09-27	CI
Canadian Investment Regulatory Organization Trade Resumption - MIR	23-08-31	AQ
Canadian Investment Regulatory Organization Trading Halt - MIR	23-08-29	AQ
MedMira's Fiscal Q3 Loss Widens, Revenue Falls	23-06-30	MT
MedMira Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-28	CI
MedMira Falls Near 17% As Widens Q2 Net Loss YOY	23-04-04	MT
MedMira Widens Q2 Net Loss YOY	23-04-04	MT
MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-04-02	CI
MedMira Inc. Provides an Update on Its Progress to Achieve Regulatory Approval in Canada for Its Reveal TP Antibody Test	23-03-14	CI
MedMira Enters into Partnership with Maternova for USA and Latin America	23-02-21	MT
MedMira enters into Partnership with Maternova for USA and Latin America	23-02-21	AQ
Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis	23-02-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News MedMira Inc.

Equities

MIR

CA58501R1029

All News

Filters